Biomimetic Therapeutics, Inc. Asset Turnover Ratio (BMTI), as of third quarter 2012, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Biomimetic Therapeutics, Inc.  (BMTI)
 

Biomimetic Therapeutics Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

Biomimetic Therapeutics's asset turnover ratio has remained unchanged compare to previous quarter at 0.03 in the third quarter (Sep 30 2012)

Within sector 7 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the Third Quarter 2012 compared to the preceding quarter from 0 to 919.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

BMTI Asset Turnover Ratio (Sep 30 2012)
III. Quarter		 (Jun 30 2012)
II. Quarter		 (Mar 31 2012)
I. Quarter		 (Dec 31 2011)
IV. Quarter		 (Sep 30 2011)
III. Quarter
Y / Y Asset Change -30.87 % -32.56 % -36.58 % - -
Y / Y Revenue Change 60.68 % -0.5 % 16.97 % 29.81 % 14.42 %
Asset Turnover Ratio (TTM) 0.03 0.03 0.02 0.02 0.02
BMTI's Total Ranking # 919 # 0 # 0 # 0 #
Seq. Asset Change -7.04 % -8.25 % -10.61 % -9.31 % -9.32 %
Seq. Revenue Change 57.56 % -6.28 % 1.75 % 6.94 % -2.44 %



Asset Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 8
Healthcare Sector # 60
Overall Market # 919

Asset Turnover Ratio Statistics
High Average Low
20.46 16.67 12.89
(Jun 30 2012)   (Sep 30 2012)




BMTI Company Profile • Back to BMTI Efficiency Comparisons • Compare BMTI Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Sep 30 2012, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Sep 30 2012 Assets at quarter ending Sep 30 2012
Savient Pharmaceuticals Inc  0.10 $ 16.786  Millions$ 170.237  Millions
Enliven Therapeutics Inc   0.10 $ 0.240  Millions$ 2.438  Millions
Inovio Pharmaceuticals Inc   0.10 $ 4.617  Millions$ 48.390  Millions
Sorrento Therapeutics Inc   0.09 $ 0.590  Millions$ 6.276  Millions
Cryoport inc   0.09 $ 0.569  Millions$ 6.079  Millions
Aspira Women s Health inc   0.09 $ 1.820  Millions$ 19.863  Millions
Cytokinetics Incorporated  0.09 $ 6.132  Millions$ 69.683  Millions
Pathfinder Cell Therapy, Inc.  0.09 $ 0.042  Millions$ 0.480  Millions
Immunogen inc   0.09 $ 17.912  Millions$ 209.381  Millions
Celldex Therapeutics inc   0.08 $ 9.988  Millions$ 119.175  Millions
Cerevel Therapeutics Holdings Inc   0.08 $ 5.371  Millions$ 67.912  Millions
Adynxx, Inc.  0.07 $ 0.989  Millions$ 13.916  Millions
Cybrdi, Inc.  0.06 $ 0.646  Millions$ 10.519  Millions
Molecular Templates Inc   0.05 $ 3.908  Millions$ 71.178  Millions
Intermune Inc  0.05 $ 20.612  Millions$ 438.426  Millions
Vaxart Inc   0.05 $ 3.988  Millions$ 88.165  Millions
American Cryostem Corporation  0.04 $ 0.021  Millions$ 0.472  Millions
Exact Sciences Corporation  0.04 $ 4.150  Millions$ 96.123  Millions
Premier Air Charter Holdings Inc   0.04 $ 2.415  Millions$ 57.890  Millions
Lumos Pharma Inc   0.04 $ 1.689  Millions$ 41.493  Millions
Inergetics Inc  0.04 $ 0.049  Millions$ 1.275  Millions
Talphera Inc   0.04 $ 1.343  Millions$ 34.905  Millions
Biomimetic Therapeutics, Inc.  0.03 $ 2.050  Millions$ 65.083  Millions
Nanomix Corp  0.02 $ 0.025  Millions$ 1.118  Millions
Bio Green Med Solution Inc   0.02 $ 0.520  Millions$ 23.416  Millions
Aveo Pharmaceuticals Inc   0.02 $ 4.851  Millions$ 254.784  Millions
Pharmacyte Biotech Inc   0.02 $ 0.040  Millions$ 2.125  Millions
Rennova Health Inc   0.02 $ 0.162  Millions$ 9.118  Millions
Geron Corporation  0.02 $ 2.271  Millions$ 134.614  Millions
Pluri Inc   0.01 $ 0.757  Millions$ 56.351  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.